424 related articles for article (PubMed ID: 25776438)
1. Review of anal cancer patients at the Ottawa hospital.
Abunassar M; Reinders J; Jonker DJ; Asmis T
Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
Bentzen AG; Guren MG; Wanderås EH; Frykholm G; Tveit KM; Wilsgaard T; Dahl O; Balteskard L
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e173-80. PubMed ID: 22436791
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease.
Fraunholz IB; Haberl A; Klauke S; Gute P; Rödel CM
Dis Colon Rectum; 2014 Apr; 57(4):423-31. PubMed ID: 24608297
[TBL] [Abstract][Full Text] [Related]
6. Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial.
Glynne-Jones R; Kadalayil L; Meadows HM; Cunningham D; Samuel L; Geh JI; Lowdell C; James R; Beare S; Begum R; Ledermann JA; Sebag-Montefiore D;
Ann Oncol; 2014 Aug; 25(8):1616-22. PubMed ID: 24827136
[TBL] [Abstract][Full Text] [Related]
7. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Gunderson LL; Winter KA; Ajani JA; Pedersen JE; Moughan J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett CG
J Clin Oncol; 2012 Dec; 30(35):4344-51. PubMed ID: 23150707
[TBL] [Abstract][Full Text] [Related]
8. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
Flam M; John M; Pajak TF; Petrelli N; Myerson R; Doggett S; Quivey J; Rotman M; Kerman H; Coia L; Murray K
J Clin Oncol; 1996 Sep; 14(9):2527-39. PubMed ID: 8823332
[TBL] [Abstract][Full Text] [Related]
9. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.
Doyen J; Benezery K; Follana P; Ortholan C; Gérard JP; Hannoun-Levi JM; Gal J; Francois E
Dis Colon Rectum; 2013 Oct; 56(10):1125-33. PubMed ID: 24022529
[TBL] [Abstract][Full Text] [Related]
11. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
12. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
El-Hadaad HA; Wahba HA; Roshdy S
J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.
Hauerstock D; Ennis RD; Grossbard M; Evans A
Clin Colorectal Cancer; 2010 Oct; 9(4):238-42. PubMed ID: 20920996
[TBL] [Abstract][Full Text] [Related]
14. Management of anal cancer in the HIV-positive population.
Kauh J; Koshy M; Gunthel C; Joyner MM; Landry J; Thomas CR
Oncology (Williston Park); 2005 Nov; 19(12):1634-8; discussion 1638-40, 1645 passim. PubMed ID: 16396154
[TBL] [Abstract][Full Text] [Related]
15. HIV positivity and anal cancer outcomes: A single-center experience.
Wieghard N; Hart KD; Kelley K; Lu KC; Herzig DO; Mitin T; Thomas CR; Tsikitis VL
Am J Surg; 2016 May; 211(5):886-93. PubMed ID: 26988618
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy for squamous cell carcinoma of the anal canal: Comparison of one versus two cycles mitomycin-C.
White EC; Goldman K; Aleshin A; Lien WW; Rao AR
Radiother Oncol; 2015 Nov; 117(2):240-5. PubMed ID: 26347494
[TBL] [Abstract][Full Text] [Related]
17. Results of age-dependent anal canal cancer treatment: a single centre retrospective study.
Claren A; Doyen J; Falk AT; Benezery K; Follana P; Frin AC; Hannoun-Lévi JM; Cavaglione G; Mari V; Gérard JP; François E
Dig Liver Dis; 2014 May; 46(5):460-4. PubMed ID: 24555918
[TBL] [Abstract][Full Text] [Related]
18. HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
Grew D; Bitterman D; Leichman CG; Leichman L; Sanfilippo N; Moore HG; Du K
Dis Colon Rectum; 2015 Dec; 58(12):1130-6. PubMed ID: 26544809
[TBL] [Abstract][Full Text] [Related]
19. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma of the anal margin: the university of Florida experience.
Balamucki CJ; Zlotecki RA; Rout WR; Newlin HE; Morris CG; Kirwan JM; George TJ; Mendenhall WM
Am J Clin Oncol; 2011 Aug; 34(4):406-10. PubMed ID: 20881476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]